健康状况

18 基于循证研究的健康状况与补充剂信息

Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.

How We Grade Evidence

每个健康状况页面按临床证据强度对补充剂成分进行排序。以下是各等级的含义：

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

Perimenopause Cognitive Changes

Affects up to 60% of women during perimenopause (typically ages 45-55)

Verbal memory difficulties Difficulty concentrating Slower processing speed +2

Anxiety-Related Cognitive Impairment

Anxiety disorders affect 19% of US adults annually

Racing thoughts Difficulty concentrating Impaired decision-making +2

Age-Related Cognitive Decline

Affects virtually all adults to some degree after age 50

Slower processing speed Difficulty with multitasking Word-finding difficulties +2

Post-Concussion Cognitive Symptoms

1.6-3.8 million concussions/year in the US; 10-30% develop persistent symptoms

Persistent headache Difficulty concentrating Memory problems +2

Chemotherapy-Related Cognitive Impairment

Reported by 17-75% of cancer patients undergoing chemotherapy

Memory difficulties Trouble concentrating Difficulty multitasking +2

Brain Fog

Reported by 20-30% of the general population

Difficulty concentrating Mental confusion Poor short-term memory +2

Attention & Focus Difficulties

Among the most reported cognitive complaints across all age groups

Difficulty sustaining attention Easy distractibility Trouble completing tasks +2

Mental Fatigue

Highly prevalent in modern knowledge-work environments

Difficulty concentrating for extended periods Increased error rates Reduced motivation +2

Sleep-Related Cognitive Impairment

35% of adults sleep less than 7 hours; 50-70 million have sleep disorders

Daytime drowsiness Impaired memory consolidation Reduced reaction time +2

Oxidative Stress & Neuroinflammation

Universal process that accelerates with age and environmental exposure

Accelerated cognitive aging Increased susceptibility to neurodegeneration Chronic low-grade brain inflammation +1

Neurotransmitter Imbalance

Contributing factor in most cognitive and mood disorders

Mood instability Cognitive slowness Reduced motivation +2

Long COVID Cognitive Symptoms

Reported by 20-30% of COVID-19 survivors

Persistent brain fog Memory difficulties Impaired executive function +2

Cerebrovascular Health

Cerebrovascular risk factors present in 60%+ of adults over 60

Reduced mental sharpness Dizziness Difficulty with complex reasoning +1

Mild Cognitive Impairment (MCI)

15-20% of adults over 65

Noticeable memory lapses Difficulty with complex reasoning Impaired judgment +2

Memory Loss

40% of adults over 65 experience some form of age-associated memory impairment

Difficulty remembering recent events Frequently misplacing items Trouble recalling names +2

Depression-Related Cognitive Dysfunction

8.4% of US adults experience major depression; cognitive symptoms in 90%+ of episodes

Impaired concentration Indecisiveness Psychomotor retardation +2

Stress-Induced Cognitive Decline

Chronic stress reported by 77% of US adults

Difficulty concentrating under pressure Memory retrieval problems Impaired decision-making +2

Nutritional Deficiency Cognitive Impairment

40% of geriatric memory patients deficient in at least one brain-related vitamin

Progressive cognitive decline Memory impairment Fatigue and brain fog +2

FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。